Literature DB >> 1821657

Antisense antivirals.

J Goodchild1.   

Abstract

The antiviral use of antisense oligonucleotides is described with particular reference to our own work on the inhibition of HIV-1. Subjects include the design, metabolism, and modification of these agents and the possible future use of ribozymes.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1821657     DOI： 10.1089/ard.1991.1.361

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN： 1050-5261


  4 in total

Review 1.  Delivery of oligonucleotides with lipid nanoparticles.

Authors:  Yuhua Wang; Lei Miao; Andrew Satterlee; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2015-02-27       Impact factor: 15.470

Review 2.  Translation-targeted therapeutics for viral diseases.

Authors:  J B Harford
Journal:  Gene Expr       Date:  1995

3.  Restoration of correct splicing in thalassemic pre-mRNA by antisense oligonucleotides.

Authors:  Z Dominski; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

4.  Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach.

Authors:  H Tanaka; P Vickart; J R Bertrand; B Rayner; F Morvan; J L Imbach; D Paulin; C Malvy
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.